Green tea (<it>Camellia sinensis</it>) and cancer prevention: a systematic review of randomized trials and epidemiological studies

1749-8546-3-12 1749-8546 Review Green tea (<it>Camellia sinensis</it>) and cancer prevention: a systematic review of randomized trials and epidemiological studies Liu Jianping Jianping.Liu@fagmed.uit.no Xing Jianmin xjm761002@163.com Fei Yutong yutong_fei@yahoo.com.cn

Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China

National Research Centre in Complementary and Alternative Medicine (NAFKAM), University of Tromso, Norway

Division of Chinese Medicine, RMIT University, Melbourne, Australia

Chinese Medicine 1749-8546 2008 3 1 12 http://www.cmjournal.org/content/3/1/12 18940008 10.1186/1749-8546-3-12 23 5 2008 22 10 2008 22 10 2008 2008 Liu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Green tea is one of the most popular beverages worldwide. This review summarizes the beneficial effects of green tea on cancer prevention.

Methods

Electronic databases, including PubMed (1966–2008), the Cochrane Library (Issue 1, 2008) and Chinese Biomedical Database (1978–2008) with supplement of relevant websites, were searched. There was no language restriction. The searches ended at March 2008. We included randomized and non-randomized clinical trials, epidemiological studies (cohort and case-control) and a meta-analysis. We excluded case series, case reports, in vitro and animal studies. Outcomes were measured with estimation of relative risk, hazard or odd ratios, with 95% confidence interval.

Results

Forty-three epidemiological studies, four randomized trials and one meta-analysis were identified. The overall quality of these studies was evaluated as good or moderate. While some evidence suggests that green tea has beneficial effects on gastrointestinal cancers, the findings are not consistent.

Conclusion

Green tea may have beneficial effects on cancer prevention. Further studies such as large and long term cohort studies and clinical trials are warranted.

Background

Tea is one of the most popular beverages around the world. Popular in countries such as China and Japan, green tea accounts for 20% of tea consumption worldwide 1.

Green tea is derived from Camellia sinensis, an evergreen shrub of the Theaceae family. Unlike black tea which is fermented, green tea is produced in a non-fermented process. Green tea may be consumed in the form of a brewed beverage or capsular extract. In some countries, tea is used as dietary supplements. In China the medicinal use of green tea dated back to 4,700 years ago. Currently, there is no established recommended dose for green tea extract. Researchers examined the effects of habitually green tea drinking on cancer prevention; however, evidence has not been corroborated 234.

The main active ingredients of green tea include polyphenolic compounds such as epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC) and epigallocatechin-3-gallate (EGCG), all of which may be responsible for the anti-carcinogenic and anti-mutagenic activities of green tea. Other polyphenols in green tea include flavanols and their glycosides and depsides such as cholorogenic acid, quinic acids, carotenoids, trigalloylglucose, lignin, protein, chlorophyll, minerals (aluminum or manganese, depending on the soil content), caffeine and a very small amount of methylxanthines 5.

Polyphenols in green tea were shown to be powerful antioxidants with anti-carcinogenic properties 6. Human studies on pharmacokinetics of polyphenols in green tea were conducted 78. The evidence suggests that ingested polyphenols and their metabolites play a role in the action against gastrointestinal cancers.

Many in vitro and in vivo studies demonstrated that polyphenols from green tea were anti-carcinogenic by inducing apoptosis and inhibiting cell-growth, cyclin-dependent kinase inhibitor and urokinase (an enzyme crucial for cancer growth) 1. Probable action mechanisms include antioxidant and free-radical scavenging activity and stimulation of detoxification systems through selective induction or modification of phase I and II metabolic enzymes.

In light of growing research findings on green tea, we conducted a systematic review of randomized clinical trials and epidemiological studies to summarize the current evidence of its beneficial and harmful effects on cancer prevention in humans.

Methods

Databases and search strategy

We searched various electronic databases, including PubMed (1966–2008) 9, the Cochrane Library (Issue 1, 2008; CD-ROM), Chinese Biomedical Database (CD-ROM, 1978–2008). No language restriction was applied. The searches ended at March 2008. The search terms used included cancer, neoplasm, green tea, tea, Camellia sinensis, diet therapy, case-control study, cohort study, clinical trial, review, systematic review and meta-analysis. We also searched the following websites to identify eligible studies: NCCAM 10, the Cancer Society 11, Complementary/Integrative Medicine Education Resources (CIMER) 12, NCI Cancer Information Summaries: Complementary and Alternative Medicine 13 and the Memorial Sloan-Kettering Cancer Center 14.

Quality assessment

As various study designs (i.e. randomized, non-randomized, prospective cohort and case-control) are included in this review, categorization after quality assessment was applied to each study 15 as follows.

Category A (good)

Studies in category A have the least biases and their results are considered valid. These studies are likely to consist of (1) clear description of the population, setting, interventions and comparison groups; (2) appropriate measurement of outcomes; (3) appropriate statistical and analytical methods; (4) no reporting errors; (5) less than 20 percent dropouts; (6) clear reporting of dropouts; and (7) appropriate consideration and adjustment for potential confounders.

Category B (fair)

Studies in category B are susceptible to some degrees of biases that are not sufficient to invalidate the results. These studies may have sub-optimal adjustments for potential confounders and may also lack certain information that is needed to assess limitations and potential problems.

Category C (poor)

Studies in category C have significant biases which may invalidate the results. These studies either do not consider potential confounders or do not make adjustments for them appropriately. These studies may have critical flaw in design, analysis and/or reporting, missing information and/or discrepancies in reporting.

Inclusion criteria

We included randomized controlled trials, controlled clinical trials or observational studies including prospective cohort and case-control studies on cancer prevention of green tea oral consumption in healthy individuals or cancer patients. Systematic reviews or meta-analyses were also included. In this review, only studies in the above mentioned categories A and B were included.

Exclusion criteria

We excluded case series, case reports, in vitro cell culture and animal studies. Poor quality studies (i.e. those in Category C) were also excluded.

Data abstraction and analysis

Relative risk (RR) or hazard ratio (HR) was used for clinical trials or cohort studies, while odds ratio (OR) was used for case-control studies. The above effect estimation was presented with 95% confidence interval (95% CI).

Due to the heterogeneity of study designs, settings, interventions and outcomes, we did not conduct a meta-analysis.

Results

A Cochrane systematic review on green tea for cancer (protocol stage) published in 2004 does not include any studies 16. This review identified 48 clinical studies investigating the consumption of green tea and its association with the risk of developing cancer, including 42 epidemiological studies 171819202122232425262728293031323334353637383940414243444546474849505152535455565758, one phase I trial 59, four randomized trials 60616263 and one meta-analysis 64 (Additional file 1). Twenty-two and 20 of the 42 epidemiological studies were cohort studies and case-control studies respectively, among which two studies 2643 reported data from four cohort studies and one cohort study 1718 and one case-control study 4142 were reported twice. All studies were published between 1984 and 2008; 44 studies were published in international journals, three in Chinese 283256 and one in Japanese 38.

Additional file 1

Summary of the included studies on green tea for cancer prevention. The table provides summarized information of the studies included in the present systematic review, including names of authors, location, study design, study quality, type of cancer, population and main findings.

Click here for file

Participants in the included studies ranged from healthy individuals, pre-cancer patients to cancer patients. Several studies reported various cancers in their cases or cohorts, but in this review these data were presented separately in relevant categories. Average sample size for cohort studies was 31,798 (from 52 to 102,137 per study), 1,099 for case-control studies (from 213 to 3,818 per study) and 182 for randomized trials (from 60 to 400 per trial). Decaffeinated green tea, tea polyphenols (500 mg or 1000 mg) or catechins was used for 3–12 months in randomized trials, whereas regular drinking tea was used for a fixed period or lifelong time in epidemiological studies. The outcomes reported from randomized trials included 8-hydroxydeoxyguanosine (8-OHdG) in urine (an indicator for oxidative DNA damage) 6062, histopathological examination 61 and incidence of cancer 63. Risk of cancer development was the main outcome for epidemiological studies; a few studies reported mortality 2023, recurrence 4749, survival of cancer 57 and sister chromatid exchange (SCE) rates 21.

Four randomized trials were placebo-controlled, double-blinded (three) and of acceptable methodological quality in terms of randomization, blinding and reporting of the studies. According to the generic quality grading for all included studies, 29 studies (60%) were evaluated as good (A) and the remaining as fair (B).

Cancer prevention

Caner in general (5 studies)

A cohort study of 8,552 people with nine years of follow-up showed a negative association of green tea consumption with cancer incidence, especially among Japanese women drinking more than ten cups a day (RR 0.59; 95% CI, 0.35–0.98) 1718. However, a larger cohort study with 38,540 people in Japan did not show an association between green tea consumption and sum incidence of all cancers (RR 1.0; 95% CI, 0.91–1.1 for those drinking two to four times per day; RR 0.98; 95%CI, 0.88–1.1 for those drinking five times or more per day, both compared with those drinking one time or less per day) 19. Another large cohort study found no significant benefit in terms of cancer mortality among a total of 1,134 cancer patients who consumed green tea and those who did not 20. A randomized trial comparing green tea, black tea with water in 143 heavy smokers found significant decrease in 8-OHdG levels after a 4-month intervention 60. A prospective cohort study in 52 male smokers demonstrated that drinking green tea inhibited cigarette-induced increase in sister chromatid exchange rates 21.

Oral and esophageal cancer (8 studies)

A prospective cohort study followed 20,550 men and 29,671 women for an average of 10.3 years and estimated the HRs (95% CI) in oral cancer 22. For women, the HRs (95% CI) were 0.51 (0.10–2.68), 0.60 (0.17–2.10) and 0.31 (0.09–1.07) for green tea consumption of one to two, three to four and five or more cups per day respectively, compared with those who drank less than one cup per day (P for trend, 0.08). For men, no trend was observed.

Inconsistent findings exist in case-control and cohort studies on green tea drinking and esophageal cancer 232425262728. Two population-based case-control studies of 3,049 subjects found a protective effect of green tea drinking against esophageal cancer among women 2425, while another case-control study of 1,043 subjects showed 39% decrease of risk of esophageal cancer among alcoholic drinkers and 31% decrease among smokers 28. The tea polyphenol epigallocatechin in urine was inversely associated with cancer risk when the data of gastric and esophageal cancer sub-sites were combined 27, indicating protective effect of green tea. However, in terms of death, a retrospective cohort and a pooled analysis of two cohort studies with a total of 26,723 subjects demonstrated a positive association (HR 1.67; 95% CI, 0.89–3.16) (P for trend, 0.04) of drinking green tea and mortality of esophageal cancer among men 2326. A randomized controlled trial with 400 participants who were pathologically confirmed to have esophageal precancerous lesions did not show benefit of decaffeinated green tea for alleviating precancerous lesions or abnormal cell proliferation compared with calcium as placebo 61.

Stomach cancer (11 studies)

Seven epidemiological studies (one cohort and six case-control studies) with a total number of 77,777 subjects showed inverse association of green tea consumption (urine polyphenol epigallocatechin in one study) and the risk reduction of stomach cancer 27283032343637. The cohort study with 72,943 subjects showed benefit for women who consumed five or more cups of green tea per day (RR 0.51; 95% CI, 0.30–0.86) compared with one cup per day 30. However, four studies including two cohort studies with 102,179 subjects did not show an inverse association of green tea consumption and risk reduction of stomach cancer or cancer-caused death 29303335.

Pancreatic cancer (4 studies)

Two case-control studies (in three publications) with 522 pancreatic cancer patients and 1,694 controls showed an inverse association of drinking green tea and the risk of pancreatic cancer 384142. By contrast, a hospital-based case-control study of 124 patients and 124 controls demonstrated a positive association of drinking five cups or more green tea per day and pancreatic cancer 39. A population-based cohort study involving 102,137 participants with 11 years of follow-up did not find any association of the risk of pancreatic cancer and drinking green tea 40.

Liver cancer (2 studies)

A population-based case-control study involving 204 patients and 415 controls reported that drinking green tea reduced the risk of liver cancer by 78% (OR 0.25; 95% CI, 0.11–0.57) among alcoholic drinkers and by 43% among smokers 28. A randomized, double-blinded, placebo-controlled trial in 124 individuals with sero-positive HBsAg and aflatoxin-albumin adducts showed a significant decrease of 8-hydroxydeoxyguanosine after three months of green tea polyphenols intake 62.

Biliary ducts cancer (1 study)

Statistical analysis showed that green tea consumption was positively associated with the mortality of biliary duct cancer in a retrospective cohort study (P ≤ 0.01) 23.

Colorectal cancer (6 studies)

Two case-control studies (in three publications) involving 2,036 patients with colorectal cancer and 2,130 controls found that drinking green tea reduced the risk of colorectal cancer 414244. Gender difference was observed in two cohort studies 4546. A prospective cohort study that followed over 60,000 subjects for an average of 8.9 years found no statistically significant difference between green tea drinkers and non-drinkers (RR 1.12; 95% CI, 0.97–1.29) 45. Another cohort study with six years of follow-up on 69,710 women found significant dose-response relationship (RR 0.63; 95% CI, 0.45–0.88) between regular and non-regular green tea drinkers 46. By contrast, a pooled analysis from two cohort studies on over 60,000 subjects showed no association between drinking green tea and a lower risk of colorectal cancer 43.

Breast cancer (5 studies)

In a meta-analysis of two prospective cohorts of 35,004 Japanese women 64, green tea intake was not associated with a lower risk of breast cancer (222 cases); and the multivariate RR for women drinking more than five cups of green tea was 0.84 (95% CI, -0.57–1.24; P = 0.69) compared with those drinking less than one cup per day. One case-control study showed significantly reduced risk of breast cancer by regular drinking a large amount of green tea 50. However, a cohort study did not find an association of green tea intake with lower risk of breast cancer 48. Another two cohort studies showed reduced recurrence of breast cancer among patients at stage I and II with high consumption of green tea (more than three cups per day) 4749.

Lung cancer (4 studies)

A randomized trial compared green tea and black tea with water in 143 heavy smokers for 4 months 60. The content of 8-OHdG in urine was reduced among the subjects in green tea group, but not in black tea or water groups. A cohort study of 52 male adults, found that green tea drinking blocked cigarette-induced increase in sister chromatid exchange rates, suggesting potential protection against lung cancer 21. Consumption of green tea was found to be associated with a reduced risk of lung cancer among non-smoking women in one case-control study 51. A phase I dose finding study showed the maximum tolerated dose of green tea extract as 3 g/m²per day in patients with advanced lung cancer. The dose-limiting toxicities were diarrhea, nausea and hypertension 59.

Prostate cancer (4 studies)

A double-blind, placebo-controlled trial testing green tea catechins (600 mg per day for one year) significantly reduced the incidence of prostate cancer in a group of 60 volunteers with high-grade prostate intraepithelial neoplasia; no significant adverse effect was reported 63. A case-control study found prostate cancer risk declined with increasing frequency, duration and quantity of green tea consumption 53. A cohort study in 19,561 Japanese men showed that green tea intake was not associated with a lower risk of prostate cancer (HR 0.85; 95% CI, 0.50–1.43) between men drinking five or more cups and less than one cup per day 54. However, another recent cohort study with a larger sample size (n = 49,920) in Japan suggested that green tea was associated with a decreased risk of advanced prostate cancer (RR 0.52; 95% CI, 0.28–0.96) in men drinking five or more cups compared with those drinking less than one cup per day 55.

Urinary bladder cancer (1 study and 1 ongoing trial)

The risk of urinary bladder cancer was significantly reduced in women who consumed matcha (a powdered green tea) in a case-control study (n = 882) 52. A phase II randomized, double-blind, placebo-controlled, multi-center trial (n = 330) is currently carried out in the United States 65.

Endometrial cancer (1 study)

A population-based case-control study (n = 2082) suggested that regular green tea drinking reduced the risk of endometrial cancer (OR 0.74; 95% CI, 0.54–1.01) in pre-menopausal women 56.

Ovarian cancer (1 study)

A cohort study (n = 254) suggested that increasing the post-diagnosis consumption of green tea may boost the survival of patients of epithelial ovarian cancer 57.

Adult leukemia (1 study)

A case-control study (n = 217) demonstrated statistical association (OR 0.51; 95% CI 0.27–0.96) between higher intake of green tea and reduced risk of adult leukemia in a dose-response manner 58.

Safety of green tea

Green tea, as a popularly consumed beverage, is relatively non-toxic 66. Phase I trial in 17 patients with advanced lung cancer showed that the maximum tolerated dose of green tea extract was 3 g/m²per day 59. No severe adverse effects have been reported in association with the medicinal use of green tea 67. Consumption of high doses of green tea or green tea extract (i.e. 5–6 litters per day) may cause nausea, vomiting, abdominal bloating/pain, dyspepsia, flatulence and diarrhea 5967. Excessive consumption of caffeine from green tea may also cause central nervous system stimulation such as dizziness, insomnia, tremors, restlessness, confusion, diuresis (i.e. increasing urine output), heart rate irregularities and psychomotor agitation 67.

Human studies did not show severe adverse effects among volunteers who took 15 tablets of green tea per day (i.e. 2.25 g green tea extracts, 337.5 mg EGCG and 135 mg caffeine) for 6 months 6869. A randomized, placebo-controlled trial (n = 40) found no adverse effect in healthy individuals who took green tea polyphenols in the amount equivalent to the EGCG content in 8–16 cups of green tea once a day or twice a day in divided doses for four weeks 69.

Discussion

Current research findings are not sufficient to validate the effects of green tea on cancer prevention as most evidence coming from cohort (grade III) and case-control studies (grade IV) is not consistent. As tea drinking is common in many populations, it is difficult to randomize subjects into drinking groups or non-drinking groups. For the same reason, epidemiological studies are still important in this field.

This review of randomized trials and epidemiological studies shows the current evidence in green tea and cancer prevention. More than half of the studies (58%) suggest that long-term consumption of green tea may reduce the risk of certain types of cancer, in particular gastrointestinal cancers, such as esophageal, stomach, pancreatic, liver and colorectal cancer. Stratified analysis suggests that women benefit more than men from green tea drinking. However, the beneficial effects are not consistent across all studies. The interpretation of these findings is a challenge due to the significantly heterogeneous study designs, settings, populations, exposures, comparisons, outcome measures and potential publication biases. The heterogeneity hinders meaningful meta-analysis despite the large number of studies covered in this systematic review. The discrepancies in the findings may be due to the following factors: (1) participants in terms of health status, family history of cancer, age, gender, ethnic and other lifestyle confounders such as smoking or alcohol drinking; (2) definitions of green tea consumption, e.g. frequency, duration, quantity of green tea and the quality of green tea products; and (3) study designs and trial settings.

This review shows that the overall evidence for protective effects of green tea against cancer is inconclusive. Therefore, further prospective cohort studies and clinical trials are warranted. Adequate sample size, better descriptions of populations and/or clear definitions of green tea consumption may be required for conclusive studies.

Moderate consumption of green tea (3–9 cups per day) is generally safe. People with known allergy/hypersensitivity to caffeine or tannin should avoid green tea. In general, the stimulatory effect of green tea is considerably less than that of coffee 66. However, pregnant women, nursing mothers and patients with cardiac conditions are advised to avoid or limit their intake of green tea to two cups per day 68.

Conclusion

Great efforts have been made to show the beneficial effects of green tea consumption on various cancers. Some epidemiological studies demonstrated protective effects of green tea consumption on gastrointestinal, breast, lung and prostate cancer. However, these findings have not been confirmed by other studies covered in this review. Future prospective studies are therefore warranted.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JPL conceived and drafted this article. JMX and YTF helped select studies and abstracted data. JPL validated the process and conducted data analysis. All authors contributed to the writing and approved the final version of the manuscript.

Acknowledgements

JPL, JMX and YTF were supported by a grant from the National Basic Research Program of China ('973' Program, No.2006CB504602) and by the '111' Project (B08006). JPL was also supported in part by a grant (No.R24 AT001293) from the National Center for Complementary and Alternative Medicine (NCCAM) of the United States National Institutes of Health (NIH).

Green tea detailed scientific review http://www.mdanderson.org/departments/cimer/ Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer Brown MD Altern Med Rev 1999 4 360 370 10559550 Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention Nakachi K Matsuyama S Miyake S Suganuma M Imai K Biofactors 2000 13 49 54 11237198 Green tea: prevention and treatment of cancer by nutraceuticals Béliveau R Gingras D Lancet 2004 364 1021 1022 10.1016/S0140-6736(04)17076-1 15380952 Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers Yang CS Chen L Lee MJ Balentine D Kuo MC Schantz SP Cancer Epidemiol Biomarkers Prev 1998 7 351 354 9568793 Mechanisms of cancer prevention by tea constituents Lambert JD Yang CS J Nutr 2003 133 3262S 3267S 14519824 Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability Lee MJ Maliakal P Chen L Meng X Bondoc FY Prabhu S Lambert G Mohr S Yang CS Cancer Epidemiol Biomarkers Prev 2002 11 1025 1032 12376503 Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Chow HH Cai Y Hakim IA Crowell JA Shahi F Brooks CA Dorr RT Hara Y Alberts DS Clin Cancer Res 2003 9 3312 3319 12960117 PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi NCCAM http://nccam.nih.gov/ American Cancer Society http://www.cancer.org/docroot/home/index.asp Complementary/Integrative Medicine Education Resources (CIMER) http://www.mdanderson.org/departments/CIMER/ NCI Cancer Information Summaries: Complementary and Alternative Medicine http://www.cancer.gov/cancerinfo/pdq/cam/ Memorial Sloan-Kettering Cancer Center http://www.mskcc.org/mskcc/html/11570.cfm Agency for Healthcare Research and Quality http://www.ahrq.gov/downloads/pub/evidence/pdf/brfout/brfout.pdf Green tea (Camellia sinensis) for the prevention of cancer. (Protocol) Schmidt K Horneber M Borrelli F Ernst E Cochrane Database of Systematic Reviews 2004 4 Cancer-preventive effects of drinking green tea among a Japanese population Imai K Suga K Nakachi K Prev Med 1997 26 769 775 10.1006/pmed.1997.0242 9388788 Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention Nakachi K Matsuyama S Miyake S Suganuma M Imai K Biofactors 2000 13 49 54 11237198 A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan) Nagano J Kono S Preston DL Mabuchi K Cancer Causes Control 2001 12 501 508 10.1023/A:1011297326696 11519758 Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study Kuriyama S Shimazu T Ohmori K Kikuchi N Nakaya N Nishino Y Tsubono Y Tsuji I JAMA 2006 296 1255 1265 10.1001/jama.296.10.1255 16968850 Chemopreventive effect of green tea (Camellia sinensis) among cigarette smokers Shim JS Kang MH Kim YH Roh JK Roberts C Lee IP Cancer Epidemiol Biomarkers Prev 1995 4 387 391 7655335 A prospective study of green tea consumption and oral cancer incidence in Japan Ide R Fujino Y Hoshiyama Y Mizoue T Kubo T Pham TM Shirane K Tokui N Sakata K Tamakoshi A Yoshimura T JACC Study Group Ann Epidemiol 2007 17 821 826 10.1016/j.annepidem.2007.04.003 17606381 Statistical analyses on the pattern of food consumption and digestive-tract cancers in Japan Hara N Sakata K Nagai M Fujita Y Hashimoto T Yanagawa H Nutr Cancer 1984 6 220 228 6545578 Reduced risk of oesophageal cancer associated with green tea consumption Gao YT McLaughlin JK Blot WJ Ji BT Dai Q Fraumeni JF Jr J Natl Cancer Inst 1994 86 855 858 10.1093/jnci/86.11.855 8182766 Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population Wang JM Xu B Rao JY Shen HB Xue HC Jiang QW Eur J Gastroenterol Hepatol 2007 19 171 176 10.1097/MEG.0b013e32800ff77a 17273005 Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men Ishikawa A Kuriyama S Tsubono Y Fukao A Takahashi H Tachiya H Tsuji I J Epidemiol 2006 16 185 192 10.2188/jea.16.185 16951537 Urinary tea polyphenols in relation to gastric and oesophageal cancers: a prospective study of men in Shanghai, China Sun CL Yuan JM Lee MJ Yang CS Gao YT Ross RK Yu MC Carcinogenesis 2002 23 1497 1503 10.1093/carcin/23.9.1497 12189193 A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers Mu LN Zhou XF Ding BG Wang RH Zhang ZF Chen CW Wei GR Zhou XM Jiang QW Yu SZ Zhonghua Liu Xing Bing Xue Za Zhi 2003 24 3 192 195 12816709 A prospective study of stomach cancer death in relation to green tea consumption in Japan Hoshiyama Y Kawaguchi T Miura Y Mizoue T Tokui N Yatsuya H Sakata K Kondo T Kikuchi S Toyoshima H Hayakawa N Tamakoshi A Ohno Y Yoshimura T Br J Cancer 2002 87 309 313 10.1038/sj.bjc.6600487 12177800 Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study Sasazuki S Inoue M Hanaoka T Yamamoto S Sobue T Tsugane S Cancer Causes Control 2004 15 483 491 10.1023/B:CACO.0000036449.68454.42 15286468 Green tea and the risk of gastric cancer in Japan Tsubono Y Nishino Y Komatsu S Hsieh CC Kanemura S Tsuji I Nakatsuka H Fukao A Satoh H Hisamichi S N Engl J Med 2001 344 632 636 10.1056/NEJM200103013440903 11228277 Epidemiological study of the influence of drinking green tea on gastric cancer and chronic gastritis incidence Yu SZ Zhang ZF Yu GP Zhu WD Li YL Wang MR Guo CH Xie ZC Chin J Cancer 2001 11 41 45 A nested case-control study of stomach cancer in relation to green tea consumption in Japan Hoshiyama Y Kawaguchi T Miura Y Mizoue T Tokui N Yatsuya H Sakata K Kondo T Kikuchi S Toyoshima H Hayakawa N Tamakoshi A Ohno Y Yoshimura T Br J Cancer 2004 90 135 138 10.1038/sj.bjc.6601512 14710220 A case-control study of gastric cancer and diet in northern Kyushu, Japan Kono S Ikeda M Tokudome S Kuratsune M Jpn J Cancer Res 1988 79 1067 1074 3143695 The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China Ji BT Chow WH Yang G McLaughlin JK Gao RN Zheng W Shu XO Jin F Fraumeni JF Jr Gao YT Cancer 1996 77 2449 2457 10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H 8640692 Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China Yu GP Hsieh CC Wang LY Yu SZ Li XL Jin TH Cancer Causes Control 1995 6 532 538 10.1007/BF00054162 8580302 Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan Tajima K Tominaga S Jpn J Cancer Res 1985 76 705 716 3930448 A case control study of cancer of the pancreas Goto R Masuoka H Yoshida K Mori M Miyake H Gan No Rinsho 1990 Spec No 344 350 2313889 A multi-institute case-control study on the risk factors of developing pancreatic cancer Mizuno S Watanabe S Nakamura K Omata M Oguchi H Ohashi K Ohyanagi H Fujiki T Motojima K Jpn J Clin Oncol 1992 22 286 291 1434027 Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study) Luo J Inoue M Iwasaki M Sasazuki S Otani T Ye W Tsugane S JPHC Study Group Eur J Cancer Prev 2007 16 542 548 18090127 Green tea consumption and the risk of pancreatic and colorectal cancers Ji BT Chow WH Hsing AW McLaughlin JK Dai Q Gao YT Blot WJ Fraumeni JF Jr Int J Cancer 1997 70 255 258 10.1002/(SICI)1097-0215(19970127)70:3<255::AID-IJC1>3.0.CO;2-W 9033623 Tobacco, alcohol and green tea consumption and pancreatic cancer: a population-based case-control study in urban Shanghai, China Dai Q Ji BT Jin F Xu M Gao YT Cancer 1996 16 5 10 Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan Suzuki Y Tsubono Y Nakaya N Koizumi Y Suzuki Y Shibuya D Tsuji I J Epidemiol 2005 15 118 124 10.2188/jea.15.118 16141630 A comparative case-control study of colorectal cancer and adenoma Kato I Tominaga S Matsuura A Yoshii Y Shirai M Kobayashi S Jpn J Cancer Res 1990 81 1101 1108 2125036 Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study Sun CL Yuan JM Koh WP Lee HP Yu MC Carcinogenesis 2007 28 2143 2148 10.1093/carcin/bgm171 17724377 Prospective cohort study of green tea consumption and colorectal cancer risk in women Yang G Shu XO Li H Chow WH Ji BT Zhang X Gao YT Zheng W Cancer Epidemiol Biomarkers Prev 2007 16 1219 1223 10.1158/1055-9965.EPI-07-0097 17548688 Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan Inoue M Tajima K Mizutani M Iwata H Iwase T Miura S Hirose K Hamajima N Tominaga S Cancer Lett 2001 167 175 182 10.1016/S0304-3835(01)00486-4 11369139 Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan Key TJ Sharp GB Appleby PN Beral V Goodman MT Soda M Mabuchi K Br J Cancer 1999 81 1248 1256 10.1038/sj.bjc.6690837 10584890 Influence of drinking green tea on breast cancer malignancy among Japanese patients Nakachi K Suemasu K Suga K Takeo T Imai K Higashi Y Jpn J Cancer Res 1998 89 254 261 9600118 Green tea and risk of breast cancer in Asian Americans Wu AH Yu MC Tseng CC Hankin J Pike MC Int J Cancer 2003 106 574 579 10.1002/ijc.11259 12845655 A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China Zhong L Goldberg MS Gao YT Hanley JA Parent ME Jin F Epidemiology 2001 12 695 700 10.1097/00001648-200111000-00019 11679799 Case-control study of urinary bladder cancer in metropolitan Nagoya Ohno Y Aoki K Obata K Morrison AS Natl Cancer Inst Monogr 1985 69 229 234 3834338 Protective effect of green tea against prostate cancer: a case-control study in southeast China Jian L Xie LP Lee AH Binns CW Int J Cancer 2004 108 130 135 10.1002/ijc.11550 14618627 No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study Kikuchi N Ohmori K Shimazu T Nakaya N Kuriyama S Nishino Y Tsubono Y Tsuji I Br J Cancer 2006 95 371 373 10.1038/sj.bjc.6603230 16804523 Green tea consumption and prostate cancer risk in Japanese men: a prospective study Kurahashi N Sasazuki S Iwasaki M Inoue M Tsugane S JPHC Study Group Am J Epidemiol 2008 167 71 77 10.1093/aje/kwm249 17906295 Green tea consumption and the risk of endometrial cancer: a population-based case-control study in urban Shanghai Gao J Xiang YB Xu WH Shao CX Ruan ZX Cheng JR Shu XO Gao YT Zhonghua Liu Xing Bing Xue Za Zhi 2005 26 5 323 327 16053753 Green tea consumption enhances survival of epithelial ovarian cancer Zhang M Lee AH Binns CW Xie X Int J Cancer 2004 112 465 469 10.1002/ijc.20456 15382073 Possible protective effect of green tea intake on risk of adult leukaemia Zhang M Zhao X Zhang X Holman CD Br J Cancer 2008 98 168 170 10.1038/sj.bjc.6604140 18087282 Phase I study of green tea extract in patients with advanced lung cancer Laurie SA Miller VA Grant SC Kris MG Ng KK Cancer Chemother Pharmacol 2005 55 33 38 10.1007/s00280-004-0859-1 15309507 Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study Hakim IA Harris RB Brown S Chow HH Wiseman S Agarwal S Talbot W J Nutr 2003 133 3303S 3309S 14519830 Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer Wang LD Zhou Q Feng CW Liu B Qi YJ Zhang YR Gao SS Fan ZM Zhou Y Yang CS Wei JP Zheng S Gan to kagaku ryoho 2002 29 suppl 1 159 172 11890101 Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine Luo H Tang L Tang M Billam M Huang T Yu J Wei Z Liang Y Wang K Zhang ZQ Zhang L Wang JS Carcinogenesis 2006 27 262 268 10.1093/carcin/bgi147 15930028 Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplassia: a preliminary report from a one-year proof-of-principle study Bettuzzi S Brausi M Rizzi F Castagnetti G Peracchia G Corti A Cancer Res 2006 66 1234 1240 10.1158/0008-5472.CAN-05-1145 16424063 Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan Suzuki Y Tsubono Y Nakaya N Suzuki Y Koizumi Y Tsuji I Br J Cancer 2004 90 1361 1363 10.1038/sj.bjc.6601652 15054454 Erlotinib and green tea extract (Polyphenon® E) in preventing cancer recurrence in former smokers who have undergone surgery for bladder cancer National Cancer Institute http://clinicaltrials.gov/ct/action/GetStudy Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer Brown MD Altern Med Rev 1999 4 360 370 10559550 The Natural Medicines Comprehensive Database http://www.naturaldatabase.com/ Mechanistic findings of green tea as cancer preventive for humans Fujiki H Suganuma M Okabe S Sueoka E Suga K Imai K Nakachi K Kimura S Proc Soc Exp Biol Med 1999 220 225 228 10.1046/j.1525-1373.1999.d01-38.x 10202393 Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Chow HH Cai Y Hakim IA Crowell JA Shahi F Brooks CA Dorr RT Hara Y Alberts DS Clin Cancer Res 2003 9 3312 3319 12960117